LPL Financial LLC Takes Position in Tactile Systems Technology, Inc. (NASDAQ:TCMD)

LPL Financial LLC purchased a new stake in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 14,938 shares of the company’s stock, valued at approximately $256,000. LPL Financial LLC owned about 0.06% of Tactile Systems Technology at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of TCMD. Jones Financial Companies Lllp bought a new stake in Tactile Systems Technology in the 4th quarter worth approximately $39,000. 1620 Investment Advisors Inc. bought a new stake in Tactile Systems Technology in the 4th quarter worth approximately $97,000. AlphaQuest LLC bought a new stake in Tactile Systems Technology in the 4th quarter worth approximately $158,000. Retireful LLC bought a new stake in Tactile Systems Technology in the 4th quarter worth approximately $173,000. Finally, SG Americas Securities LLC lifted its position in Tactile Systems Technology by 12.7% in the 4th quarter. SG Americas Securities LLC now owns 12,032 shares of the company’s stock worth $206,000 after buying an additional 1,354 shares during the last quarter. Institutional investors own 83.43% of the company’s stock.

Tactile Systems Technology Price Performance

Shares of Tactile Systems Technology stock opened at $14.17 on Tuesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 4.36 and a quick ratio of 3.80. The business’s 50 day simple moving average is $13.74 and its two-hundred day simple moving average is $15.73. The stock has a market capitalization of $335.35 million, a P/E ratio of 20.24 and a beta of 1.21. Tactile Systems Technology, Inc. has a one year low of $11.12 and a one year high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.09. The business had revenue of $85.59 million for the quarter, compared to analysts’ expectations of $85.39 million. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. Analysts forecast that Tactile Systems Technology, Inc. will post 0.7 EPS for the current year.

Insider Activity

In related news, Director Daniel L. Reuvers sold 10,938 shares of Tactile Systems Technology stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $14.55, for a total transaction of $159,147.90. Following the sale, the director now directly owns 242,942 shares in the company, valued at $3,534,806.10. The trade was a 4.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Elaine M. Birkemeyer sold 3,778 shares of Tactile Systems Technology stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $14.70, for a total value of $55,536.60. Following the sale, the chief financial officer now owns 104,098 shares in the company, valued at $1,530,240.60. This represents a 3.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 19,546 shares of company stock valued at $285,444. Company insiders own 2.50% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on TCMD shares. StockNews.com downgraded Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 29th. B. Riley downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $23.00 to $18.00 in a research report on Wednesday, February 19th.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.